Clinical Trial Update: CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)

View source ↗

Summary

This clinical trial update discusses the potential influence of CYP19 genetic polymorphism on aromatase inhibitor therapy in breast cancer, with listed conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Exemestane (Exemestane)
• Letrozole (letrozole)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Breast Neoplasms, Arthralgia | Status: UNKNOWN